Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission.
Nishiwaki S, Inamoto Y, Sakamaki H, Kurokawa M, Iida H, Ogawa H, Fukuda T, Ozawa Y, Kobayashi N, Kasai M, Mori T, Iwato K, Yoshida T, Onizuka M, Kawa K, Morishima Y, Suzuki R, Atsuta Y, Miyamura K. Nishiwaki S, et al. Among authors: mori t. Blood. 2010 Nov 18;116(20):4368-75. doi: 10.1182/blood-2010-02-269571. Epub 2010 Jul 27. Blood. 2010. PMID: 20664060 Free article.
Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
Mori T, Mori S, Kanda Y, Yakushiji K, Mineishi S, Takaue Y, Gondo H, Harada M, Sakamaki H, Yajima T, Iwao Y, Hibi T, Okamoto S. Mori T, et al. Among authors: mori s. Bone Marrow Transplant. 2004 Feb;33(4):431-4. doi: 10.1038/sj.bmt.1704369. Bone Marrow Transplant. 2004. PMID: 14676775
Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.
Tanimoto TE, Yamaguchi T, Tanaka Y, Saito A, Tajima K, Karasuno T, Kasai M, Kishi K, Mori T, Maseki N, Morishima S, Miyakoshi S, Kasai M, Ohno Y, Kim SW, Numata A, Kami M, Takaue Y, Mori S, Harada M. Tanimoto TE, et al. Among authors: mori t, mori s. Br J Haematol. 2004 May;125(4):480-93. doi: 10.1111/j.1365-2141.2004.04943.x. Br J Haematol. 2004. PMID: 15142119 Free article.
Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan.
Kusumi E, Kami M, Kanda Y, Murashige N, Kishi Y, Suzuki R, Takeuchi K, Tanimoto TE, Mori T, Muta K, Tamaki T, Tanaka Y, Ogawa H, Yamane T, Taniguchi S, Takaue Y. Kusumi E, et al. Among authors: mori t. Bone Marrow Transplant. 2005 Aug;36(3):205-13. doi: 10.1038/sj.bmt.1705027. Bone Marrow Transplant. 2005. PMID: 15937505
Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor.
Kanda Y, Hyo R, Yamashita T, Fujimaki K, Oshima K, Onoda M, Mori T, Sakura T, Tanaka M, Sakai M, Taguchi J, Kurakawa M, Maruta A, Okamoto S, Sakamaki H; Kanto Study Group of Cell Therapy. Kanda Y, et al. Among authors: mori t. Am J Hematol. 2006 Nov;81(11):838-44. doi: 10.1002/ajh.20710. Am J Hematol. 2006. PMID: 16888784 Free article.
Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
Yamane A, Mori T, Suzuki S, Mihara A, Yamazaki R, Aisa Y, Nakazato T, Shimizu T, Ikeda Y, Okamoto S. Yamane A, et al. Among authors: mori t. Biol Blood Marrow Transplant. 2007 Jan;13(1):100-6. doi: 10.1016/j.bbmt.2006.09.003. Biol Blood Marrow Transplant. 2007. PMID: 17222758 Free article.
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S. Mori T, et al. Biol Blood Marrow Transplant. 2008 Jun;14(6):651-7. doi: 10.1016/j.bbmt.2008.03.006. Biol Blood Marrow Transplant. 2008. PMID: 18489990 Free article.
9,431 results